Halyard IV Start Kit Non-Sterile REF: KRIV26-02 Recall
Halyard IV Start Kit Non-Sterile REF: KRIV26-02
FDA recall Class II
Ongoing
FDA lists this Class II recall for Halyard IV Start Kit Non-Sterile REF: KRIV26-02. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-3109-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Jul 14, 2026
- FDA report date
- Sep 16, 2026
- Quantity in commerce
- 98 Kits
- Distribution
- See key details
- FDA cause
- Packaging process control
What is being recalled?
Halyard IV Start Kit Non-Sterile REF: KRIV26-02
Affected model & UDI checker
Search the exact identifiers published for Z-3109-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| KRIV26-02 | Halyard IV Start Kit Non-Sterile REF: KRIV26-02 | Check source notice | Not specified |
| Not specified | Halyard IV Start Kit Non-Sterile REF: KRIV26-02 | Check source notice | 10809160460481 |
FDA code information
Lot Number:1658438 7/31/2026 UDI: 10809160460481
Why was this product recalled?
Convenience kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which lacks sterility assurance due to to wrinkles in the paper lidding which may breach the seal area.
What actions did AVID Medical, Inc. take?
On July 14, 2026, Avid Medical Inc. a subsidiary of Owens Minor issued an Urgent Medical Device Recall to affected consignees via email. I Avid Medical Inc. requested consignees to take the following actions: 1. Identify, segregate, and quarantine all impacted product identified. 1a. Discontinue use of the BD ChloraPrep" Clear - 1 mL and FREPP" Clear 1.5 mL Applicators. 1b. Add warning labels to affected AVID kits to ensure all users are aware of the actions to discard the impacted component prior to use. A labeling template is enclosed for printing labels which can be affixed on all affected kits and cases in inventory. This label should be applied in a prominently visible location to end-users. The location chosen should not cover any other critical product information found on existing product labeling. 2. Customers (end-users): If you received product from a distributor, please contact the distributor or your sales representative with any questions you may have. 3. Distributors: If any of the affected kits identified above were further distributed, please ensure all end-users are appropriately notified and maintain records of effectiveness. 4. Complete the attached Recall Response Form and return by July 31, 2026.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-3109-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 19, 2026
- openFDA device recall record · Source release Nov 14, 2026 · Retrieved Nov 19, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology